Business Context and Reporting Period
This Form 8-K Current Report was filed by Corbus Pharmaceuticals Holdings, Inc. on October 11, 2022, covering events occurring on October 11 and October 12, 2022. The filing details corporate governance changes, specifically a bylaw amendment regarding quorum requirements and the declaration of a dividend of Series A Preferred Stock.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate actions and capital structure adjustments.
Material Changes
- Bylaw Amendment: On October 11, 2022, the Board amended Section 5 of Article I of the Bylaws. The quorum requirement for stockholder meetings is now clarified as the presence of holders representing one-third of the voting power of issued and outstanding shares entitled to vote, and one-third of the issued and outstanding Common Stock shares entitled to vote.
- Series A Preferred Stock Dividend: On October 12, 2022, the Board declared a dividend of 0.008 of a share of Series A Preferred Stock for each outstanding share of Common Stock. The record date is October 22, 2022.
Outlook, Risks, and Unusual Items
Purpose of Preferred Stock: The Series A Preferred Stock is designed to vote exclusively on proposals to adopt a reverse stock split. Each 0.008 share of Preferred Stock entitles the holder to 500,000 votes. The stock ranks senior to Common Stock in liquidation but carries no dividend rights.
Redemption Terms: Shares of Preferred Stock not present at a meeting to vote on a reverse stock split will be automatically redeemed. Redemption consideration is $0.001 in cash for every ten whole shares beneficially owned. Holders of less than ten whole shares receive no cash payment. Remaining shares are redeemed automatically upon the effectiveness of a reverse stock split or at the Board's discretion.
Transferability: Preferred Stock is uncertificated and can only be transferred in connection with the transfer of Common Stock.
Investor Verification Checklist
- Verify the specific quorum threshold (one-third of voting power and one-third of shares) for upcoming stockholder meetings.
- Confirm the record date of October 22, 2022, for entitlement to the Series A Preferred Stock dividend.
- Review the Certificate of Designation (Exhibit 3.2) for full details on the voting power (62,500,000 votes per share) and redemption mechanics of the Preferred Stock.
- Assess the potential impact of the Preferred Stock on the ability to approve a reverse stock split, given the significant voting weight attached to the dividend shares.